SOURCE: InforSense Ltd.

March 26, 2008 09:00 ET

InforSense to Host Translational Research Symposium

John Quackenbush, Ph.D. of the Dana-Farber Cancer Institute to Keynote

CAMBRIDGE, MA--(Marketwire - March 26, 2008) - InforSense Ltd., the leading provider of embedded enterprise intelligence, today announced the company will host a Translational Research Symposium on Friday, May 2, 2008 at the Exchange Conference Center in Boston, Massachusetts.

The Translational Research Symposium will provide a forum for members of the clinical, pharmaceutical and research communities who are involved in or interested in embarking on translational research projects. Speakers will discuss strategies for success in translational research -- the practice of linking clinical and research data to identify biomarkers, improve disease understanding and ultimately improve patient care. John Quackenbush, Ph.D. of the Dana-Farber Cancer Institute will present the opening keynote presentation on "Translational Research and Gene Expression at the Dana-Farber Cancer Institute." Additional speakers will include Erasmus University Medical Center's Peter van der Spek, Deloitte Consulting LLP's Keith Strier, Children's Hospital of Philadelphia's Hakon Hakonarson, Strategic Medicine Inc.'s Michael Liebman and Jonathan Sheldon of InforSense.

"Translational Research is providing powerful methods to identify disease and efficacy biomarkers, which support a more efficient and targeted approach to Research and Development in Pharma and Biotech companies. By combining experimental approaches used in drug discovery with data from clinical trials and more general patient information, researchers are able to design and test their hypotheses more effectively," said Jonathan Sheldon, Chief Scientific Officer at InforSense. "However, there are significant IT challenges in integrating clinical data from patient histories, lab results, pathology reports and clinical questionnaires. Bringing clinical and research data together is a daunting prospect that requires an effective informatics infrastructure."

Topics for discussion will include:

-- Translational Research and Gene Expression

-- Clinical Decision Support

-- Translational Research for CNS Using Image Analysis and Other Technologies

-- Genetic Analysis and Translational Research

-- Informatics Requirements for Translational Research

-- The Future of Translational Research

-- Biobanking and Translational Research

-- Translational Genetics

-- Roadblocks to Translational Research in Big Pharma

The Translational Research Symposium will be held immediately following the InforSense User Group Meeting, which takes place April 30-May 2 at the Exchange Conference Center in Boston.

To register for the Translational Research Symposium go to: http://www.inforsense.com/company/translational_research_symposium/

For more information contact InforSense at transresearch@inforsense.com.

About InforSense

InforSense Ltd., the leader in agile, predictive, and visual embedded enterprise analytics, enables organizations to orchestrate and optimize their business-critical decision-making processes. Leading pharmaceutical and biotechnology, consumer goods, healthcare, financial services, manufacturing and communications companies are using the company's flagship product, InforSense, to enhance productivity by embedding analytics within their business processes. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts.

For more information visit www.inforsense.com.

InforSense and the InforSense logo are registered trademarks of InforSense Limited. All rights reserved. All other trademarks mentioned in this document are the property of their respective owners.

Contact Information

  • Contact:
    Lisa Allocca
    Red Javelin Communications, Inc.
    978-470-2227
    Email Contact